← Open Payments lookup

DONNA KASPER: Open Payments

NPI 1568647030 · OPELOUSAS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$675 in 25 payments from 10 companies in 2025. Trend: 2023 $587 · 2024 $716 · 2025 $675

Food & beverage: $675
CompanyPaymentsAmount
Sumitomo Pharma America, Inc.9$194
Janssen Scientific Affairs, LLC1$135
UROGEN PHARMA, INC.3$104
Janssen Biotech, Inc.5$96
Boston Scientific Corporation2$40
PFIZER INC.1$25
Ferring Pharmaceuticals Inc.1$24
AstraZeneca Pharmaceuticals LP1$22
TOLMAR, INC.1$20
Endo USA, Inc.1$16

Products named: ERLEADA, GEMTESA, JELMYTO, XTANDI, ADSTILADRIN, Axonics, LYNPARZA, JATENZO.

Industry payments across LA — which companies pay providers there.